JAC Advance Access published online on August 30, 2007
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkm315
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Correspondence |
Results of a UK survey of fatal anaphylaxis after oral amoxicillin
1 Medicines and Healthcare products Regulatory Agency, Market Towers, 1 Nine Elms Lane, London SW5 8NQ, UK 2 Department of Medical Microbiology, Great Ormond Street Hospital for Sick Children, London WC1N 3JH, UK
* Corresponding author. Tel: +44-207-084-2874; E-mail: paul.lee@mhra.gsi.gov.uk
Key Words: BSAC guidelines , prevention , endocarditis , dental procedures
| The first 10% of the full text of this article appears below. |
Sir,
A single high dose of oral amoxicillin has been the main antibiotic regimen recommended for the prophylaxis of endocarditis since 1982,1 and there has been good compliance with this recommendation in the UK.2 However, the fear that the number of deaths from anaphylaxis associated with amoxicillin prophylaxis could exceed the number of deaths from endocarditis that might be prevented from prophylaxis was one factor leading the BSAC Working Party to discontinue recommending prophylaxis for most susceptible cardiac patients undergoing dental
Funding
Transparency declarations
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. C. Shanson Comment on: New guidance from NICE regarding antibiotic prophylaxis for infective endocarditis - response by the BSAC Working Party J. Antimicrob. Chemother., March 1, 2009; 63(3): 629 - 630. [Full Text] [PDF] |
||||
